Cargando…

Comparison of diagnoses of early-onset sepsis associated with use of Sepsis Risk Calculator versus NICE CG149: a prospective, population-wide cohort study in London, UK, 2020–2021

OBJECTIVE: We sought to compare the incidence of early-onset sepsis (EOS) in infants ≥34 weeks’ gestation identified >24 hours after birth, in hospitals using the Kaiser Permanente Sepsis Risk Calculator (SRC) with hospitals using the National Institute for Health and Care Excellence (NICE) guida...

Descripción completa

Detalles Bibliográficos
Autores principales: Piyasena, Chinthika, Galu, Sorana, Yoshida, Rie, Thakkar, Devangi, O'Sullivan, Joanna, Longley, Catherine, Evans, Katie, Sweeney, Suzanne, Kendall, Giles, Ben-Sasi, Khadija, Richards, Justin, Harris, Chris, Jagodzinski, Jenni, Demirjian, Alicia, Lamagni, Theresa, Le Doare, Kirsty, Heath, Paul T, Battersby, Cheryl
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10387649/
https://www.ncbi.nlm.nih.gov/pubmed/37500270
http://dx.doi.org/10.1136/bmjopen-2023-072708
_version_ 1785081930220306432
author Piyasena, Chinthika
Galu, Sorana
Yoshida, Rie
Thakkar, Devangi
O'Sullivan, Joanna
Longley, Catherine
Evans, Katie
Sweeney, Suzanne
Kendall, Giles
Ben-Sasi, Khadija
Richards, Justin
Harris, Chris
Jagodzinski, Jenni
Demirjian, Alicia
Lamagni, Theresa
Le Doare, Kirsty
Heath, Paul T
Battersby, Cheryl
author_facet Piyasena, Chinthika
Galu, Sorana
Yoshida, Rie
Thakkar, Devangi
O'Sullivan, Joanna
Longley, Catherine
Evans, Katie
Sweeney, Suzanne
Kendall, Giles
Ben-Sasi, Khadija
Richards, Justin
Harris, Chris
Jagodzinski, Jenni
Demirjian, Alicia
Lamagni, Theresa
Le Doare, Kirsty
Heath, Paul T
Battersby, Cheryl
author_sort Piyasena, Chinthika
collection PubMed
description OBJECTIVE: We sought to compare the incidence of early-onset sepsis (EOS) in infants ≥34 weeks’ gestation identified >24 hours after birth, in hospitals using the Kaiser Permanente Sepsis Risk Calculator (SRC) with hospitals using the National Institute for Health and Care Excellence (NICE) guidance. DESIGN AND SETTING: Prospective observational population-wide cohort study involving all 26 hospitals with neonatal units colocated with maternity services across London (10 using SRC, 16 using NICE). PARTICIPANTS: All live births ≥34 weeks’ gestation between September 2020 and August 2021. OUTCOME MEASURES: EOS was defined as isolation of a bacterial pathogen in the blood or cerebrospinal fluid (CSF) culture from birth to 7 days of age. We evaluated the incidence of EOS identified by culture obtained >24 hours to 7 days after birth. We also evaluated the rate empiric antibiotics were commenced >24 hours to 7 days after birth, for a duration of ≥5 days, with negative blood or CSF cultures. RESULTS: Of 99 683 live births, 42 952 (43%) were born in SRC hospitals and 56 731 (57%) in NICE hospitals. The overall incidence of EOS (<72 hours) was 0.64/1000 live births. The incidence of EOS identified >24 hours was 2.3/100 000 (n=1) for SRC vs 7.1/100 000 (n=4) for NICE (OR 0.5, 95% CI (0.1 to 2.7)). This corresponded to (1/20) 5% (SRC) vs (4/45) 8.9% (NICE) of EOS cases (χ=0.3, p=0.59). Empiric antibiotics were commenced >24 hours to 7 days after birth in 4.4/1000 (n=187) for SRC vs 2.9/1000 (n=158) for NICE (OR 1.5, 95% CI (1.2 to 1.9)). 3111 (7%) infants received antibiotics in the first 24 hours in SRC hospitals vs 8428 (15%) in NICE hospitals. CONCLUSION: There was no significant difference in the incidence of EOS identified >24 hours after birth between SRC and NICE hospitals. SRC use was associated with 50% fewer infants receiving antibiotics in the first 24 hours of life.
format Online
Article
Text
id pubmed-10387649
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-103876492023-08-01 Comparison of diagnoses of early-onset sepsis associated with use of Sepsis Risk Calculator versus NICE CG149: a prospective, population-wide cohort study in London, UK, 2020–2021 Piyasena, Chinthika Galu, Sorana Yoshida, Rie Thakkar, Devangi O'Sullivan, Joanna Longley, Catherine Evans, Katie Sweeney, Suzanne Kendall, Giles Ben-Sasi, Khadija Richards, Justin Harris, Chris Jagodzinski, Jenni Demirjian, Alicia Lamagni, Theresa Le Doare, Kirsty Heath, Paul T Battersby, Cheryl BMJ Open Paediatrics OBJECTIVE: We sought to compare the incidence of early-onset sepsis (EOS) in infants ≥34 weeks’ gestation identified >24 hours after birth, in hospitals using the Kaiser Permanente Sepsis Risk Calculator (SRC) with hospitals using the National Institute for Health and Care Excellence (NICE) guidance. DESIGN AND SETTING: Prospective observational population-wide cohort study involving all 26 hospitals with neonatal units colocated with maternity services across London (10 using SRC, 16 using NICE). PARTICIPANTS: All live births ≥34 weeks’ gestation between September 2020 and August 2021. OUTCOME MEASURES: EOS was defined as isolation of a bacterial pathogen in the blood or cerebrospinal fluid (CSF) culture from birth to 7 days of age. We evaluated the incidence of EOS identified by culture obtained >24 hours to 7 days after birth. We also evaluated the rate empiric antibiotics were commenced >24 hours to 7 days after birth, for a duration of ≥5 days, with negative blood or CSF cultures. RESULTS: Of 99 683 live births, 42 952 (43%) were born in SRC hospitals and 56 731 (57%) in NICE hospitals. The overall incidence of EOS (<72 hours) was 0.64/1000 live births. The incidence of EOS identified >24 hours was 2.3/100 000 (n=1) for SRC vs 7.1/100 000 (n=4) for NICE (OR 0.5, 95% CI (0.1 to 2.7)). This corresponded to (1/20) 5% (SRC) vs (4/45) 8.9% (NICE) of EOS cases (χ=0.3, p=0.59). Empiric antibiotics were commenced >24 hours to 7 days after birth in 4.4/1000 (n=187) for SRC vs 2.9/1000 (n=158) for NICE (OR 1.5, 95% CI (1.2 to 1.9)). 3111 (7%) infants received antibiotics in the first 24 hours in SRC hospitals vs 8428 (15%) in NICE hospitals. CONCLUSION: There was no significant difference in the incidence of EOS identified >24 hours after birth between SRC and NICE hospitals. SRC use was associated with 50% fewer infants receiving antibiotics in the first 24 hours of life. BMJ Publishing Group 2023-07-27 /pmc/articles/PMC10387649/ /pubmed/37500270 http://dx.doi.org/10.1136/bmjopen-2023-072708 Text en © Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Paediatrics
Piyasena, Chinthika
Galu, Sorana
Yoshida, Rie
Thakkar, Devangi
O'Sullivan, Joanna
Longley, Catherine
Evans, Katie
Sweeney, Suzanne
Kendall, Giles
Ben-Sasi, Khadija
Richards, Justin
Harris, Chris
Jagodzinski, Jenni
Demirjian, Alicia
Lamagni, Theresa
Le Doare, Kirsty
Heath, Paul T
Battersby, Cheryl
Comparison of diagnoses of early-onset sepsis associated with use of Sepsis Risk Calculator versus NICE CG149: a prospective, population-wide cohort study in London, UK, 2020–2021
title Comparison of diagnoses of early-onset sepsis associated with use of Sepsis Risk Calculator versus NICE CG149: a prospective, population-wide cohort study in London, UK, 2020–2021
title_full Comparison of diagnoses of early-onset sepsis associated with use of Sepsis Risk Calculator versus NICE CG149: a prospective, population-wide cohort study in London, UK, 2020–2021
title_fullStr Comparison of diagnoses of early-onset sepsis associated with use of Sepsis Risk Calculator versus NICE CG149: a prospective, population-wide cohort study in London, UK, 2020–2021
title_full_unstemmed Comparison of diagnoses of early-onset sepsis associated with use of Sepsis Risk Calculator versus NICE CG149: a prospective, population-wide cohort study in London, UK, 2020–2021
title_short Comparison of diagnoses of early-onset sepsis associated with use of Sepsis Risk Calculator versus NICE CG149: a prospective, population-wide cohort study in London, UK, 2020–2021
title_sort comparison of diagnoses of early-onset sepsis associated with use of sepsis risk calculator versus nice cg149: a prospective, population-wide cohort study in london, uk, 2020–2021
topic Paediatrics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10387649/
https://www.ncbi.nlm.nih.gov/pubmed/37500270
http://dx.doi.org/10.1136/bmjopen-2023-072708
work_keys_str_mv AT piyasenachinthika comparisonofdiagnosesofearlyonsetsepsisassociatedwithuseofsepsisriskcalculatorversusnicecg149aprospectivepopulationwidecohortstudyinlondonuk20202021
AT galusorana comparisonofdiagnosesofearlyonsetsepsisassociatedwithuseofsepsisriskcalculatorversusnicecg149aprospectivepopulationwidecohortstudyinlondonuk20202021
AT yoshidarie comparisonofdiagnosesofearlyonsetsepsisassociatedwithuseofsepsisriskcalculatorversusnicecg149aprospectivepopulationwidecohortstudyinlondonuk20202021
AT thakkardevangi comparisonofdiagnosesofearlyonsetsepsisassociatedwithuseofsepsisriskcalculatorversusnicecg149aprospectivepopulationwidecohortstudyinlondonuk20202021
AT osullivanjoanna comparisonofdiagnosesofearlyonsetsepsisassociatedwithuseofsepsisriskcalculatorversusnicecg149aprospectivepopulationwidecohortstudyinlondonuk20202021
AT longleycatherine comparisonofdiagnosesofearlyonsetsepsisassociatedwithuseofsepsisriskcalculatorversusnicecg149aprospectivepopulationwidecohortstudyinlondonuk20202021
AT evanskatie comparisonofdiagnosesofearlyonsetsepsisassociatedwithuseofsepsisriskcalculatorversusnicecg149aprospectivepopulationwidecohortstudyinlondonuk20202021
AT sweeneysuzanne comparisonofdiagnosesofearlyonsetsepsisassociatedwithuseofsepsisriskcalculatorversusnicecg149aprospectivepopulationwidecohortstudyinlondonuk20202021
AT kendallgiles comparisonofdiagnosesofearlyonsetsepsisassociatedwithuseofsepsisriskcalculatorversusnicecg149aprospectivepopulationwidecohortstudyinlondonuk20202021
AT bensasikhadija comparisonofdiagnosesofearlyonsetsepsisassociatedwithuseofsepsisriskcalculatorversusnicecg149aprospectivepopulationwidecohortstudyinlondonuk20202021
AT richardsjustin comparisonofdiagnosesofearlyonsetsepsisassociatedwithuseofsepsisriskcalculatorversusnicecg149aprospectivepopulationwidecohortstudyinlondonuk20202021
AT harrischris comparisonofdiagnosesofearlyonsetsepsisassociatedwithuseofsepsisriskcalculatorversusnicecg149aprospectivepopulationwidecohortstudyinlondonuk20202021
AT jagodzinskijenni comparisonofdiagnosesofearlyonsetsepsisassociatedwithuseofsepsisriskcalculatorversusnicecg149aprospectivepopulationwidecohortstudyinlondonuk20202021
AT demirjianalicia comparisonofdiagnosesofearlyonsetsepsisassociatedwithuseofsepsisriskcalculatorversusnicecg149aprospectivepopulationwidecohortstudyinlondonuk20202021
AT lamagnitheresa comparisonofdiagnosesofearlyonsetsepsisassociatedwithuseofsepsisriskcalculatorversusnicecg149aprospectivepopulationwidecohortstudyinlondonuk20202021
AT ledoarekirsty comparisonofdiagnosesofearlyonsetsepsisassociatedwithuseofsepsisriskcalculatorversusnicecg149aprospectivepopulationwidecohortstudyinlondonuk20202021
AT heathpault comparisonofdiagnosesofearlyonsetsepsisassociatedwithuseofsepsisriskcalculatorversusnicecg149aprospectivepopulationwidecohortstudyinlondonuk20202021
AT battersbycheryl comparisonofdiagnosesofearlyonsetsepsisassociatedwithuseofsepsisriskcalculatorversusnicecg149aprospectivepopulationwidecohortstudyinlondonuk20202021
AT comparisonofdiagnosesofearlyonsetsepsisassociatedwithuseofsepsisriskcalculatorversusnicecg149aprospectivepopulationwidecohortstudyinlondonuk20202021